MAPK1 and heart failure: In vivo studies, and data acquired from heart failure patients, suggest that p38 contributes to the progression of heart failure but that this is not through the aggravation of hypertrophy (Ng et al., 2003; Nishida et al., 2004; See et al., 2004; Klein et al., 2005).